GlowSense is a GMP-certified cosmetic contract manufacturer in Ravenhall, Victoria — powered by the patent-pending One Pot Process (OPP) Method. We deliver heat-sensitive actives at 33–91× conventional penetration. Zero prior art worldwide.
Certified by SGS Australia
AU 2026901796 · OPP Method
43.5% refundable R&D offset
Zero active degradation
Ravenhall VIC 3023
Standard cosmetic emulsification at 70–75°C destroys the actives that matter most — peptides, postbiotics, growth factors, Vitamin C derivatives, retinol and enzymatic actives are all denatured before the product reaches your consumer.
The One Pot Process is a patent-pending cold-process, single-vessel co-formulation technique. Marine bio-spicules from Haliclona sp. (oxea-type, 100–400 µm) are combined with actives at ambient temperature in one vessel. On skin application, spicules create transient microchannels in the stratum corneum for genuine sub-epidermal delivery.
Global prior art search across AU, US, EP, CN, KR and WO: zero prior art confirmed. Patent application AU 2026901796 filed 5 March 2026.
From formulation brief to shelf-ready product — ISO 22716 GMP-certified, Ravenhall VIC. MOQ from 500 units.
Australia's only patent-pending cold-process bio-spicule co-formulation. 33–91× transdermal delivery. Exclusively at GlowSense.
Bespoke cosmetic formulation from brief to bench. Any format, any active. OPP or conventional. Full BMR and CoA. NDA from day one.
Fast-to-market private label from our OPP formulation library. GS-003, GS-004 and GS-002-A available from 500 units with your branding.
Full ODM and OEM service. Raw materials, production, QC, fill-finish and dispatch. GMP batch records and CoA on every run.
ISO 22716 by SGS, AICIS compliance, TGA-aligned docs, DAFF export certificates for EU, UK, US and Asian market entry.
Apply the One Pot Process to your existing formulations. Co-manufacturing agreements and PCT filing March 2027 for global coverage.
50ml · Triple Peptide 13.5% — Capixyl 6%, Matrixyl 3000 5%, Copper Tripeptide 2.5%. All heat-labile above 45°C. OPP delivers intact peptide complex to the hair follicle dermis.
30ml · Niacinamide 10% + Signal Peptide Complex cold-process co-formulated with bio-spicules. Sub-epidermal delivery for genuine brightening beyond surface diffusion.
30ml · SAP Vitamin C + Ferulic Acid + Alpha-Arbutin — cold-process preserves 100% SAP activity. OPP bio-spicule delivery reaches the fibroblast layer for collagen synthesis stimulation.
The OPP Method unlocks a full spectrum of heat-sensitive actives that conventional hot-process manufacturing cannot formulate without destroying.
Certified by SGS Australia. Annual surveillance audit. Accepted for EU, UK, US and Asian export documentation.
Formally registered with ATO & AusIndustry. 43.5% refundable offset on eligible R&D. Adviser: RADBE Consulting.
AU 2026901796. GlowSense Holdings Pty Ltd. Zero global prior art (6 jurisdictions). PCT filing March 2027.
Advisory Service approved IGPAS007206. Government recognition as advanced manufacturing business.
We are raising AUD $500K to commercialise the OPP Method — Australia's first patent-pending cold-process transdermal delivery platform. Revenue-generating from day one. GMP operational. Zero global prior art confirmed.
Send us your active brief. We respond within 48 hours. NDA signed before any technical discussion. MOQ from 500 units.